Published on in Vol 22, No 3 (2020): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17921, first published .
The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

Journals

  1. Ness N, Schriefer D, Haase R, Ettle B, Ziemssen T. Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis. PharmacoEconomics 2020;38(8):883 View
  2. Voigt I, Benedict M, Susky M, Scheplitz T, Frankowitz S, Kern R, Müller O, Schlieter H, Ziemssen T. A Digital Patient Portal for Patients With Multiple Sclerosis. Frontiers in Neurology 2020;11 View
  3. Schriefer D, Haase R, Ettle B, Ziemssen T. Patient‐ versus physician‐reported relapses in multiple sclerosis: insights from a large observational study. European Journal of Neurology 2020;27(12):2531 View
  4. Ziemssen T, Hoffmann O, Klotz L, Schreiber H, Weber M, Rauser B. Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA. JMIR Research Protocols 2020;9(7):e19598 View
  5. Haase R, Schriefer D, Ziemssen T. Der Patient als Experte. DNP - Der Neurologe & Psychiater 2020;21(5):33 View
  6. Scholz M, Haase R, Schriefer D, Voigt I, Ziemssen T. Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice. Brain Sciences 2021;11(2):180 View
  7. Schriefer D, Ness N, Haase R, Ziemssen T. Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients. Therapeutic Advances in Neurological Disorders 2020;13:175628642096027 View
  8. Ness N, Schriefer D, Haase R, Ziemssen T. Der Multiple Sclerosis Health Resource Utilization Survey. Fortschritte der Neurologie · Psychiatrie 2021 View